Summary
As perioperative prophylaxis for major orthopedic operations 81 patients were given the fixed combination of ampicillin (1 g)/ sulbactam (0.5 g) or cefotiam (2 g) as short infusions. The three β-lactams were rapidly distributed into the different tissues and their pharmacokinetic profiles were found to be very similar. It was noteworthy that ampicillin, sulbactam and cefotiam penetrated within minutes, not only into skin, fat and muscles, but also into bone. Thus 0.25 h after starting the infusion the following mean concentrations were measured in bone: 21.8±10.5 mg/kg ampicillin, 4.9±2.2 mg/kg sulbactam and 19.4±10.6 mg/kg cefotiam. For a period of at least 2 h the concentrations measured in serum and in the different tissues affected by the operation (skin, fat, muscle, bone) were above the MICs for pathogens which are involved in postoperative wound infections. On the basis of pharmacokinetic data, ampicillin/sulbactam and cefotiam seem about equally suitable for perioperative prophylaxis in major orthopedic operations.
Similar content being viewed by others
References
Bodoky, A., Neff, U., Heberer, M., Harder, F. Antibiotic prophylaxis with two doses of cephalosporin in patients managed with internal fixation for a fracture of the hip. J. Bone Joint Surg. 75 (1993) 61–65.
Schneider, W., Tiesler, E., Riedel, G. Konzentrationen von Cefotiam in Knochen und Serum bei Applikation zur perioperativen Prophylaxe in der Orthopädie. Zeitschr. antimikr. antineoplast. Chemother. 3 (1985) 143–146.
Kernodle, D. S., Classen, D. C., Burke, J. P., Kaiser, A. B. Failure of cephalosporins to preventStaphylococcus aureus surgical wound infections. JAMA 263 (1990) 961–966.
English, A. R., Retsema, J. A., Girard, A. E., Lynch, J. E., Barth, W. E. CP 45899, a β-lactamase-inhibitor that extends the antibacterial spectrum of β-lactams: initial bacteriological characterization. Antimicrob. Agents Chemother. 14 (1978) 414–419.
Frank, U., Daschner, F. D. In vitro activity of sulbactam plus ampicillin against hospital isolates of coagulase-negative staphylococci andAcinetobacter spp. Infection 17 (1989) 272–274.
Heizmann, W. R., Heilmann, F., Egeler, B., Werner, H. Efficacy of sulbactam in anin vitro model of mixed aerobic/anaerobic infections. Infection 18 (1990) 117–121.
Wildfeuer, A., Müller, V., Springsklee, M., Sonntag, H.-G. Pharmacokinetics of ampicillin and sulbactam in patients undergoing heart surgery. Antimicrob. Agents Chemother. 35 (1991) 1772–1776.
Heinzel, G., Woloszczak, R., Thomann, P. Topfit version 2.0. Pharmacokinetic and pharmacodynamic data analysis system for the PC. Gustav Fischer, Stuttgart 1993.
Blaufuss, H. Welches Cephalosporin zur Therapie und Prophylaxe von Knocheninfectionen? Akt. Chir. 18 (1983) 135–137.
Löffler, L., Bauernfeind, A., Keyl, W. Sulbactam/ampicillin versus cefotaxime as initial therapy in serious soft tissue, joint and bone infections. Drugs 35 (Suppl. 7) (1988) 46–52.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wildfeuer, A., Mallwitz, J., Gotthardt, H. et al. Pharmacokinetics of ampicillin, sulbactam and cefotiam in patients undergoing orthopedic surgery. Infection 25, 258–262 (1997). https://doi.org/10.1007/BF01713160
Issue Date:
DOI: https://doi.org/10.1007/BF01713160